Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists

Matthew D. Morin, Ying Wang, Brian T. Jones, Lijing Su, Murali M.R.P. Surakattula, Michael Berger, Hua Huang, Elliot K. Beutler, Hong Zhang, Bruce Beutler, Dale L. Boger

Research output: Contribution to journalArticlepeer-review

Abstract

Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.

Original languageAmerican English
Pages (from-to)4812-4830
Number of pages19
JournalJournal of Medicinal Chemistry
Volume59
Issue number10
DOIs
StatePublished - 26 May 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Molecular Medicine

Fingerprint

Dive into the research topics of 'Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists'. Together they form a unique fingerprint.

Cite this